KURA conference presentation: a negative outcome, -11.4%

On June 1, 2026, Kura Oncology, Inc. reached its conference presentation. The result was a negative outcome, and the stock moved -11.4% in the window around the event. It had already run +16.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.